Paul A. Dickinson

AstraZeneca R&D, Alderley Park
Macclesfield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Physiologically Based Biopharmaceutics Modelling-Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary Report.

Physiologically Based Biopharmaceutics Modelling-Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary Report.

Journal: Pharmaceutics

Published: March 17, 2026

Surge Dose® Formulations of NSAIDs Provide for Ultra-Rapid and Consistent Drug Absorption in Both the Fasted and Fed State as Predicted by Physiologically Based Biopharmaceutics Modelling.

Surge Dose® Formulations of NSAIDs Provide for Ultra-Rapid and Consistent Drug Absorption in Both the Fasted and Fed State as Predicted by Physiologically Based Biopharmaceutics Modelling.

Journal: Pharmaceutics

Published: March 19, 2025

Determining bioequivalence possibilities of long acting injectables through population PK modelling.

Determining bioequivalence possibilities of long acting injectables through population PK modelling.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: August 26, 2022

Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series.

Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series.

Journal: Pharmaceutics

Published: April 03, 2022

Is Thoracic Radiotherapy an Absolute Contraindication for Treatment of Lung Cancer Patients With Interstitial Lung Disease? A Systematic Review.

Is Thoracic Radiotherapy an Absolute Contraindication for Treatment of Lung Cancer Patients With Interstitial Lung Disease? A Systematic Review.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: October 29, 2021

Correction to: Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products.

Correction to: Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products.

Journal: The AAPS journal

Published: December 03, 2020

Exploring a model-based analysis of patient derived xenograft studies in oncology drug development.

Exploring a model-based analysis of patient derived xenograft studies in oncology drug development.

Journal: PeerJ

Published: October 08, 2020

Applications of Physiologically Based Biopharmaceutics Modeling (PBBM) to Support Drug Product Quality: A Workshop Summary Report.

Applications of Physiologically Based Biopharmaceutics Modeling (PBBM) to Support Drug Product Quality: A Workshop Summary Report.

Journal: Journal of pharmaceutical sciences

Published: September 22, 2020

Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products.

Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products.

Journal: The AAPS journal

Published: April 22, 2020

Effect of multiple-dose osimertinib on the pharmacokinetics of simvastatin and rosuvastatin.

Effect of multiple-dose osimertinib on the pharmacokinetics of simvastatin and rosuvastatin.

Journal: British journal of clinical pharmacology

Published: March 12, 2018

The effect of itraconazole and rifampicin on the pharmacokinetics of osimertinib.

The effect of itraconazole and rifampicin on the pharmacokinetics of osimertinib.

Journal: British journal of clinical pharmacology

Published: October 16, 2017

The Effect of Food or Omeprazole on the Pharmacokinetics of Osimertinib in Patients With Non-Small-Cell Lung Cancer and in Healthy Volunteers.

The Effect of Food or Omeprazole on the Pharmacokinetics of Osimertinib in Patients With Non-Small-Cell Lung Cancer and in Healthy Volunteers.

Journal: Journal of clinical pharmacology

Published: July 06, 2017

Showing 1-12 of 29

Last Updated: 09/26/2026